Daewon Pharmaceutical Co. Ltd. | Ownership
Companies that own Daewon Pharmaceutical Co. Ltd.
National Pension Service of Korea
2,089,031
10.94%
8,682
0.03%
06/29/2018
Fidelity Management & Research Co.
1,871,384
9.8%
-1
0%
04/30/2018
Franklin Templeton Investment Trust Management Co., Ltd.
777,022
4.07%
-241,764
10.22%
07/31/2017
FIL Investment Management (Singapore) Ltd.
685,754
3.59%
-14,031
0.14%
05/31/2018
Dimensional Fund Advisors LP
249,483
1.31%
16,557
0%
04/30/2018
TIAA-CREF Investment Management LLC
94,387
0.49%
0
0%
03/31/2018
Norges Bank Investment Management
51,995
0.27%
-16,560
0%
12/31/2017
RAM Active Investments SA
51,229
0.27%
51,229
0.02%
06/30/2017
State Street Global Advisors Ltd.
33,589
0.18%
0
0%
09/05/2018
Mirae Asset Global Investments Co., Ltd.
23,276
0.12%
5,475
0%
04/30/2018
| Address |
386 Cheonho-daero
Seoul SL 04808
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.daewonpharm.com |
| Updated |
07/08/2019 |
| Daewon Pharmaceutical Co., Ltd. engages in the production and sale of pharmaceutical products. It offers multivitamins, antipyretics, analgesics and antiinflammatory, gastrointestinal, endocrine, antimicrobial, psychoneurotic, respiratory, cardiovascular and neuromuscular drugs. The company was founded by Baek Boo-Hyeon on August 9, 1961 and is headquartered in Seoul, South Korea. |
